Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| HilleVax, Inc. | 6,724,000 | 6,724,000 | 0 | $97.23M | $11.83M | 31.18% | -$85.39M |
| Wave Life Sciences, Inc.SHS(WVE) | 1,346,892 | 1,346,892 | 0 | $6.72M | $11.04M | 29.10% | +$4.32M |
| Ovid Therapeutics Inc.(OVID) | 7,531,996 | 7,531,996 | 0 | $5.79M | $8.89M | 23.42% | +$3.10M |
| Shattuck Labs, Inc.(STTK) | 515,619 | 515,619 | 0 | $1.99M | $1.80M | 4.74% | -$190.8K |
| Equillium, Inc.(EQ) | 1,824,977 | 1,824,977 | 0 | $1.26M | $1.51M | 3.99% | +$255.5K |
| Xilio Therapeutics, Inc.(XLO) | 1,475,121 | 1,475,121 | 0 | $1.40M | $1.16M | 3.06% | -$236.0K |
| American Well CorporationCL A(AMWL) | 1,554,669 | 77,733 | -1,476,936 | $505.3K | $736.9K | 1.94% | +$231.6K |
| Turnstone Biologics Corp. | 895,824 | 895,824 | 0 | $2.35M | $499.0K | 1.31% | -$1.85M |
| Rani Therapeutics Holdings, Inc.CL A(RANI) | 215,172 | 203,190 | -11,982 | $817.7K | $438.9K | 1.16% | -$378.8K |
| Standard BioTools Inc.(LAB) | 16,515 | 16,515 | 0 | $29.2K | $31.9K | 0.08% | +$2.6K |
| Denali Therapeutics Inc.(DNLI) | 4,214,559 | 0 | -4,214,559 | $97.86M | $0 | — | -$97.86M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,557,063 | 0 | -1,557,063 | $16.04M | $0 | — | -$16.04M |
| Akili, Inc. | 738,819 | 0 | -738,819 | $321.4K | $0 | — | -$321.4K |